PHARMACOLOGICAL CORRECTION OF FETOPLACENTAL INSUFFICIENCY WITH FETAL GROWTH RETARDATION SYNDROME
Introduction: fetoplacental insufficiency (FPI) is an important problem of obstetrics. This pathological condition leads to the development of fetal growth retardation syndrome (FGRS). Any standard treatment regimens cannot exist due to a combination of individual etiological factors and pathogeneti...
Saved in:
Main Authors: | Olga Klycheva (Author), Galina Lazareva (Author), Anna Khuraseva (Author) |
---|---|
Format: | Book |
Published: |
Belgorod National Research University,
2017-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
FETOPLACENTAL ANGIOGENESIS IN PREGNANT WOMEN WITH PLACENTAL INSUFFICIENCY
by: O. V. Makarov, et al.
Published: (2016) -
INFLUENCE OF FETOPLACENTAL INSUFFICIENCY ON THE FORMATION OF PERINATAL PATHOLOGY IN PRETERM NEONATES
by: N. P. Molokanova, et al.
Published: (2013) -
Overview of fetal growth retardation/restriction
by: Chun-Chieh Chia, et al.
Published: (2014) -
Thrombophilia in the pathogenesis of fetal growth retardation
by: E. A. Orudzhova, et al.
Published: (2021) -
RISK FACTORS FOR FETAL GROWTH RETARDATION
by: Елена Николаевна Кравченко, et al.
Published: (2020)